AA
IRMD icon

ALPS Advisors’s iRadimed IRMD Stock Holding History

ALPS Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482K Buy
5,041
+71
+1% +$6.47K ﹤0.01% 992
2026
Q1 		$478K Sell
4,970
-1,483
-23% -$148K ﹤0.01% 897
2025
Q4 		$628K Buy
6,453
+51
+0.8% +$4.38K ﹤0.01% 672
2025
Q3 		$456K Sell
6,402
-575
-8% -$38.3K ﹤0.01% 775
2025
Q2 		$417K Buy
6,977
+84
+1% +$4.6K ﹤0.01% 739
2025
Q1 		$362K Sell
6,893
-410
-6% -$23K ﹤0.01% 718
2024
Q4 		$402K Hold
7,303
– – ﹤0.01% 691
2024
Q3 		$367K Sell
7,303
-697
-9% -$32.2K ﹤0.01% 763
2024
Q2 		$352K Sell
8,000
-40
-0.5% -$1.7K ﹤0.01% 730
2024
Q1 		$354K Buy
+8,040
New +$355K ﹤0.01% 814

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ALPS Advisors's IRMD Position: Q2 2026 in Review

ALPS Advisors increased its iRadimed (IRMD) stake by 1.4% in Q2 2026, buying an estimated $6.47K and bringing the position to 5,041 shares worth $482K. The position accounts for ﹤0.01% of the portfolio, ranked #992.

ALPS Advisors first reported a position in IRMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $628K in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • ALPS Advisors held 5,041 shares of iRadimed worth $482K as of Q2 2026.
  • ALPS Advisors bought 71 iRadimed shares in Q2 2026, an estimated $6.47K.
  • iRadimed made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #992 holding.
  • ALPS Advisors first reported a position in iRadimed in Q1 2024 and has held it in 10 quarters since.
  • ALPS Advisors's iRadimed position peaked at $628K in Q4 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.